Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A form of Creutzfeldt-Jakob disease that is most commonly contracted after consuming meat from an animal suffering from bovine spongiform encephalopathy.
Biomarker and diagnostic research for variant Creutzfeldt-Jakob disease has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for variant Creutzfeldt-Jakob disease.
28 publications have been identified in PubMed for variant Creutzfeldt-Jakob disease. Research spans Basic Science / Preclinical (29%), Epidemiology / Natural History (29%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 8 | 29% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression
8 |
29% |
Research summaries | 5 | 18% |
Testing and diagnosis research | 3 | 11% |
Patient case studies | 3 | 11% |
Other research | 1 | 4% |
Verity CM (2026). [PMID: 41024403](https://pubmed.ncbi.nlm.nih.gov/41024403/). *Dev Med Child Neurol*. [Epidemiology / Natural History]
De Pedro-Cuesta J (2026). [PMID: 41853150](https://pubmed.ncbi.nlm.nih.gov/41853150/). *Front Public Health*. [Epidemiology / Natural History]
Li L (2026). [PMID: 41894154](https://pubmed.ncbi.nlm.nih.gov/41894154/). *Prion*. [Case Report / Case Series]
Hagiwara K (2026). [PMID: 41555693](https://pubmed.ncbi.nlm.nih.gov/41555693/). *Microbiol Immunol*. [Basic Science / Preclinical]
Böhmer MF (2026). [PMID: 41672428](https://pubmed.ncbi.nlm.nih.gov/41672428/). *Rofo*. [Diagnostic / Biomarker]
Pedrosa DA (2025). [PMID: 39969023](https://pubmed.ncbi.nlm.nih.gov/39969023/). *Einstein (Sao Paulo)*. [Diagnostic / Biomarker]
Verity C (2025). [PMID: 40175067](https://pubmed.ncbi.nlm.nih.gov/40175067/). *Arch Dis Child*. [Epidemiology / Natural History]
Roberts B (2025). [PMID: 41466604](https://pubmed.ncbi.nlm.nih.gov/41466604/). *Lancet Reg Health Eur*. [Epidemiology / Natural History]
Cervenak J (2025). [PMID: 41490576](https://pubmed.ncbi.nlm.nih.gov/41490576/). *Emerg Infect Dis*. [Basic Science / Preclinical]
Lestari TD (2025). [PMID: 40092198](https://pubmed.ncbi.nlm.nih.gov/40092198/). *Open Vet J*. [Review / Meta-Analysis]
AI-curated news mentioning variant Creutzfeldt-Jakob disease
Updated Sep 15, 2026
A recent publication discusses the advancements in diagnostic methods for Creutzfeldt-Jakob disease, highlighting the contrast with the lack of effective therapies. The article emphasizes the need for continued research to bridge the gap between diagnosis and treatment.
A recent study highlights a case of genetic Creutzfeldt-Jakob disease linked to a 5-octapeptide repeat insertion in the PRNP gene. This research contributes to the understanding of the genetic factors involved in this rare neurodegenerative disorder.
A recent case report details the clinical analysis of three patients diagnosed with sporadic Creutzfeldt-Jakob disease, contributing to the understanding of this rare neurodegenerative disorder. The findings may provide insights into disease progression and patient management.
The Senate has introduced resolution SRES 499 to support the goals of 'Creutzfeldt-Jakob Disease Awareness Day.' This resolution has been referred to the Committee on Health, Education, Labor, and Pensions for further consideration.
The House has referred HRES 872, which supports the goals of 'Creutzfeldt-Jakob Disease Awareness Day,' to the Committee on Energy and Commerce. This resolution aims to raise awareness about CJD, a rare and fatal neurodegenerative disorder.